Covered recipient · General Payments record
MARIYA BOYCHEV
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2025
$325.36
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.98 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $54.71 | 2 |
| Astellas Pharma US Inc | $47.50 | 2 |
| EMD Serono, Inc. | $45.18 | 2 |
| SK Life Science, Inc. | $29.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.81 | 1 |
| UCB, Inc. | $23.66 | 1 |
| Amneal Pharmaceuticals LLC | $22.36 | 1 |
| CYCLE PHARMACEUTICALS INC | $18.26 | 1 |
| ABBVIE INC. | $13.90 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (13)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.90 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205263924 | CMS |
| Amgen Inc. | $30.35 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228842664 | CMS |
| Amgen Inc. | $24.36 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228842657 | CMS |
| Amneal Pharmaceuticals LLC | $22.36 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220555440 | CMS |
| Astellas Pharma US Inc | $26.27 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238639844 | CMS |
| Astellas Pharma US Inc | $21.23 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238669215 | CMS |
| Cycle Pharmaceuticals Inc | $18.26 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248899905 | CMS |
| EMD Serono, Inc. | $25.00 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236871878 | CMS |
| EMD Serono, Inc. | $20.18 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236872044 | CMS |
| Novartis Pharmaceuticals Corporation | $13.87 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200206755 | CMS |
| SK Life Science, Inc. | $29.73 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252303774 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.81 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224063284 | CMS |
| UCB, Inc. | $23.66 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224357028 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.